Bio-Techne Corp (TECH)
Receivables turnover
| Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 1,219,640 | 1,159,060 | 1,136,700 | 1,105,600 | 931,032 |
| Receivables | US$ in thousands | 206,876 | 241,394 | 218,468 | 194,548 | 145,385 |
| Receivables turnover | 5.90 | 4.80 | 5.20 | 5.68 | 6.40 |
June 30, 2025 calculation
Receivables turnover = Revenue ÷ Receivables
= $1,219,640K ÷ $206,876K
= 5.90
The receivables turnover ratio for Bio-Techne Corp demonstrates a downward trend over the period from June 2021 to June 2024, with an average decline in the ratio indicating changes in the company's receivables management or revenue recognition practices. Specifically, the ratio decreased from 6.40 times in June 2021 to 5.20 times in June 2023, reflecting an increase in average accounts receivable relative to sales or potentially a slowing in collection efficiency.
This gradual decline suggests that the company is collecting its receivables slightly less frequently over this period, which could imply elongated collection periods or evolving credit policies. However, in June 2025, the ratio experiences a notable reversal, rising to 5.90 times. This increase indicates an improvement in receivables collection efficiency or possible adjustments in credit terms to accelerate cash inflows.
Overall, the variance in the receivables turnover ratio over these years reflects periods of both deceleration and subsequent recovery in accounts receivable collections. These dynamics are important for assessing the company's liquidity position, working capital management, and operational efficiency related to credit policies.
Peer comparison
Jun 30, 2025